CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
COMPREHENSIVE INCOME
Net Earnings	$ 808	$ 1,307	$ 2,290	$ 2,674
Other Comprehensive Income/(Loss):
Foreign currency translation	(37)	16	(22)	28
Foreign currency translation on net investment hedges	41	(5)	29	(57)
Derivatives qualifying as cash flow hedges, net of taxes of $(8) and $15 for the three months ended June 30, 2012 and 2011, respectively; and $(17) and $26 for the six months ended June 30, 2012 and 2011, respectively	22	(31)	27	(57)
Derivatives qualifying as cash flow hedges reclassified to net earnings, net of taxes of $4 and $(6) for the three months ended June 30, 2012 and 2011, respectively; and $6 and $(7) for the six months ended June 30, 2012 and 2011, respectively	(9)	12	(15)	13
Pension and postretirement benefits, net of taxes of $(1) and $(6) for the three and six months ended June 30, 2012			14
Pension and postretirement benefits reclassified to net earnings, net of taxes of $0 and $(11) for the three months ended June 30, 2012 and 2011, respectively; and $(12) and $(19) for the six months ended June 30, 2012 and 2011	22	18	46	37
Available for sale securities, net of taxes of $(8) for the three months ended June 30, 2011 and $(1) and $(3) for the six months ended June 30, 2012 and 2011, respectively	10	15	7	18
Available for sale securities reclassified to net earnings, net of taxes of $2 for both the three and six months ended June 30, 2012	2		(8)
Total Other Comprehensive Income/(Loss)	51	25	78	(18)
Comprehensive Income	859	1,332	2,368	2,656
Comprehensive Income Attributable to Noncontrolling Interest	163	405	544	786
Comprehensive Income Attributable to Bristol-Myers Squibb Company	$ 696	$ 927	$ 1,824	$ 1,870